1
|
Jayaraj P, Shavi GV, Srinivasan AK, Raghavendra R, Sivaramakrishna A, Desikan R. A pre-formulation strategy for the liposome encapsulation of new thioctic acid conjugates for enhanced chemical stability and use as an efficient drug carrier for MPO-mediated atherosclerotic CVD treatment. NEW J CHEM 2020. [DOI: 10.1039/c9nj05258e] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Lipoyl-apocynin and lipoyl-sesamol are bio-active conjugates of thioctic acid, synthesized using a benign chemical approachviathe combination of thioctic acid and the powerful bio-phytonutrients, apocynin and sesamol, respectively.
Collapse
Affiliation(s)
- Premkumar Jayaraj
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore
- India
| | - Gopal Venkatesh Shavi
- South Easter Applied Material Research Centre
- Waterford Institute of Technology
- Ireland
| | | | - Ramesh Raghavendra
- South Easter Applied Material Research Centre
- Waterford Institute of Technology
- Ireland
| | - Akella Sivaramakrishna
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore
- India
| | - Rajagopal Desikan
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore
- India
| |
Collapse
|
2
|
Kalombo L, Lemmer Y, Semete-Makokotlela B, Ramalapa B, Nkuna P, Booysen LLLIJ, Naidoo S, Hayeshi R, Verschoor JA, Swai HS. Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment. NANOMATERIALS 2019; 9:nano9081167. [PMID: 31443150 PMCID: PMC6724112 DOI: 10.3390/nano9081167] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Revised: 07/21/2019] [Accepted: 07/28/2019] [Indexed: 11/16/2022]
Abstract
Aiming to improve the treatment outcomes of current daily tuberculosis (TB) chemotherapy over several months, we investigated whether nanoencapsulation of existing drugs would allow decreasing the treatment frequency to weekly, thereby ultimately improving patient compliance. Nanoencapsulation of three first-line anti-TB drugs was achieved by a unique, scalable spray-drying technology forming free-flowing powders in the nanometer range with encapsulation efficiencies of 82, 75, and 62% respectively for rifampicin, pyrazinamide, and isoniazid. In a pre-clinical study on TB infected mice, we demonstrate that the encapsulated drugs, administered once weekly for nine weeks, showed comparable efficacy to daily treatment with free drugs over the same experimental period. Both treatment approaches had equivalent outcomes for resolution of inflammation associated with the infection of lungs and spleens. These results demonstrate how scalable technology could be used to manufacture nanoencapsulated drugs. The formulations may be used to reduce the oral dose frequency from daily to once weekly in order to treat uncomplicated TB.
Collapse
Affiliation(s)
- Lonji Kalombo
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| | - Yolandy Lemmer
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa.
| | | | - Bathabile Ramalapa
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| | - Patric Nkuna
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| | | | - Saloshnee Naidoo
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| | - Rose Hayeshi
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| | - Jan A Verschoor
- Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria 0002, South Africa
| | - Hulda S Swai
- Council for Scientific and Industrial Research, Pretoria 0002, South Africa
| |
Collapse
|
3
|
Attar A, Bakir C, Yuce-Dursun B, Demir S, Cakmakci E, Danis O, Birbir M, Ogan A. Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes. Chem Biol Drug Des 2017; 91:153-161. [DOI: 10.1111/cbdd.13066] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Revised: 05/08/2017] [Accepted: 06/10/2017] [Indexed: 11/29/2022]
Affiliation(s)
- Azade Attar
- Department of Bioengineering; Faculty of Chemical and Metallurgical Engineering; Yildiz Technical University; Istanbul Turkey
| | - Ceren Bakir
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Basak Yuce-Dursun
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Serap Demir
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Emrah Cakmakci
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Ozkan Danis
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Meral Birbir
- Department of Biology; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| | - Ayse Ogan
- Department of Chemistry; Faculty of Arts and Sciences; Marmara University; Istanbul Turkey
| |
Collapse
|
4
|
Lemmer Y, Kalombo L, Pietersen RD, Jones AT, Semete-Makokotlela B, Van Wyngaardt S, Ramalapa B, Stoltz AC, Baker B, Verschoor JA, Swai HS, de Chastellier C. Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis. J Control Release 2015; 211:94-104. [PMID: 26055640 DOI: 10.1016/j.jconrel.2015.06.005] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2015] [Revised: 06/02/2015] [Accepted: 06/04/2015] [Indexed: 12/23/2022]
Abstract
The appearance of drug-resistant strains of Mycobacterium tuberculosis (Mtb) poses a great challenge to the development of novel treatment programmes to combat tuberculosis. Since innovative nanotechnologies might alleviate the limitations of current therapies, we have designed a new nanoformulation for use as an anti-TB drug delivery system. It consists of incorporating mycobacterial cell wall mycolic acids (MA) as targeting ligands into a drug-encapsulating Poly dl-lactic-co-glycolic acid polymer (PLGA), via a double emulsion solvent evaporation technique. Bone marrow-derived mouse macrophages, either uninfected or infected with different mycobacterial strains (Mycobacterium avium, Mycobacterium bovis BCG or Mtb), were exposed to encapsulated isoniazid-PLGA nanoparticles (NPs) using MA as a targeting ligand. The fate of the NPs was monitored by electron microscopy. Our study showed that i) the inclusion of MA in the nanoformulations resulted in their expression on the outer surface and a significant increase in phagocytic uptake of the NPs; ii) nanoparticle-containing phagosomes were rapidly processed into phagolysosomes, whether MA had been included or not; and iii) nanoparticle-containing phagolysosomes did not fuse with non-matured mycobacterium-containing phagosomes, but fusion events with mycobacterium-containing phagolysosomes were clearly observed.
Collapse
Affiliation(s)
- Yolandy Lemmer
- Polymers and Composites, Council for Scientific and Industrial Research, Pretoria, South Africa.
| | - Lonji Kalombo
- Polymers and Composites, Council for Scientific and Industrial Research, Pretoria, South Africa
| | - Ray-Dean Pietersen
- DST-CBTBR Department Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa
| | - Arwyn T Jones
- Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Wales, UK
| | | | | | - Bathabile Ramalapa
- Polymers and Composites, Council for Scientific and Industrial Research, Pretoria, South Africa
| | - Anton C Stoltz
- Department of Infectious Diseases, University of Pretoria, Pretoria, South Africa
| | - Bienyameen Baker
- DST-CBTBR Department Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa
| | - Jan A Verschoor
- Department of Biochemistry, University of Pretoria, Pretoria, South Africa
| | - Hulda S Swai
- Polymers and Composites, Council for Scientific and Industrial Research, Pretoria, South Africa
| | - Chantal de Chastellier
- Centre d'Immunologie de Marseille-Luminy (CIML), Aix Marseille University, UM 2, INSERM UMR 1104, CNRS UMR 7280, 163 avenue de Luminy, 13288 Marseille Cedex 09, France
| |
Collapse
|
5
|
Singh H, Jindal S, Singh M, Sharma G, Kaur IP. Nano-formulation of rifampicin with enhanced bioavailability: Development, characterization and in-vivo safety. Int J Pharm 2015; 485:138-51. [DOI: 10.1016/j.ijpharm.2015.02.050] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2014] [Revised: 02/17/2015] [Accepted: 02/18/2015] [Indexed: 11/25/2022]
|
6
|
Li K, Zhu M, Xu P, Xi Y, Cheng Z, Zhu Y, Ye X. Three-dimensionally plotted MBG/PHBHHx composite scaffold for antitubercular drug delivery and tissue regeneration. JOURNAL OF MATERIALS SCIENCE. MATERIALS IN MEDICINE 2015; 26:102. [PMID: 25655503 DOI: 10.1007/s10856-015-5455-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2014] [Accepted: 12/07/2014] [Indexed: 06/04/2023]
Abstract
A suitable drug-loaded scaffold that can postoperatively release an antituberculosis drug efficiently in a lesion area and help repair a bone defect is very important in the clinical treatment of bone tuberculosis (TB). In this study, a composite drug-loaded cylindrical scaffold was prepared by using three-dimensional printing technology in combination with the mesoporous confinement range, surface chemical groups, and gradual degradation of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). This achieves the slow release of a drug for as long as possible. We implanted the drug-loaded compound scaffold into New Zealand rabbits' femur defect model to study the in vivo drug release performance and osteogenic ability. The in vivo release of isoniazid and rifampicin from the prepared composites could be effectively sustained for 12 weeks in local tissues, whereas these drugs were sustained for just 2 weeks in a control group. The blood drug concentrations were very low and most concentrations were below 5 μg/ml. Therefore, the systemic toxic adverse effect is very low. In addition, the composite exhibits good osteogenic potential in a rabbit bone defect model. The results of this study indicate that this composite has great potential for treating osteoarticular TB.
Collapse
Affiliation(s)
- Kun Li
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, No. 500 Nanjing West Road, Shanghai, 200003, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
7
|
Beh CC, Mammucari R, Foster NR. Formation of nanocarrier systems by dense gas processing. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2014; 30:11046-11054. [PMID: 25162492 DOI: 10.1021/la502594k] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Nanocarrier systems, such as liposomes, polymersomes, and micelles, find applications in the delivery of a wide range of compounds, including targeted delivery of pharmaceuticals. Nanocarrier systems have the ability to increase the bioavailability, reduce toxicity, and avoid undesirable interactions of active pharmaceutical ingredients. In this work, a novel dense gas technique known as depressurization of an expanded solution into aqueous media (DESAM) was used to produce different types of nanocarrier systems. The effects of using different types of dense gases and different operating temperatures were investigated. Encapsulation of hydrophilic compounds in the vesicles (liposomes and polymersomes) was also studied. The highest encapsulation efficiencies in liposomes and polymersomes achieved were 10.2 and 9.7%, respectively. The DESAM process was also able to reduce the residual solvent content in the product to 2.2% (v/v), which is significantly lower than the solvent residual levels reported for conventional processing.
Collapse
Affiliation(s)
- Chau Chun Beh
- School of Chemical Engineering, University of New South Wales (UNSW) , Sydney, New South Wales 2052, Australia
| | | | | |
Collapse
|
8
|
Durán N, De Oliveira AF, De Azevedo MMM. In VitroStudies on the Release of Isoniazid Incorporated in Poly(ε-Caprolactone). J Chemother 2013; 18:473-9. [PMID: 17127222 DOI: 10.1179/joc.2006.18.5.473] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
A polymeric micro- and nanosphere formulation using poly (epsilon-caprolactone) (PCL) to entrap an antituberculosis drug, isoniazid (INH), was developed and characterized. The microspheres were prepared by a solvent evaporation method using ethyl acetate, PCL and INH as the organic phase and water and Tween 40 as the aqueous phase. The nanospheres were prepared by a spontaneous emulsification solvent diffusion method using 40% ethanol in acetone (v/v), PCL and INH as the organic phase and water and Tween 40 as the aqueous phase. After freeze-drying, these systems were characterized by scanning electron microscopy (SEM), particle size analysis, determination of entrapped INH content, in vitro INH release and brine shrimp toxicity bioassay.
Collapse
Affiliation(s)
- N Durán
- Instituto de Química, Biological Chemistry Laboratory, Universidade Estadual de Campinas, C.P. 6159, Campinas CEP 13083-970, S.P., Brazil.
| | | | | |
Collapse
|
9
|
Kumar G, Sharma S, Shafiq N, Khuller GK, Malhotra S. Optimization, in vitro–in vivo Evaluation, and Short-term Tolerability of Novel Levofloxacin-loaded PLGA Nanoparticle Formulation. J Pharm Sci 2012; 101:2165-76. [DOI: 10.1002/jps.23087] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2011] [Revised: 11/19/2011] [Accepted: 01/31/2012] [Indexed: 01/22/2023]
|
10
|
Xue M, Hu H, Jiang Y, Liu J, He H, Ye X. Biodegradable Polymer-Coated, Gelatin Hydrogel/Bioceramics Ternary Composites for Antitubercular Drug Delivery and Tissue Regeneration. JOURNAL OF NANOMATERIALS 2012; 2012:1-8. [DOI: 10.1155/2012/530978] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/21/2023]
Abstract
A simple and effective strategy for the treatment of osteoarticular tuberculosis is proposed through combining tissue engineering approach with anti-tuberculosis drug therapy. A series of tricalcium phosphate bioceramics (TPB) composites, coated by degradable polymer outside and loaded with rifampicin (RFP)-containing gelatin hydrogel inside, were thus fabricated and successfully applied to deliver antitubercular drug RFP into osseous lesion and concomitantly to induce tissue regeneration. RFP-loaded gelatin hydrogel/TPB composites could be readily prepared by filling RFP-containing gelatin solution into TPB and thenin situcrosslinking of gelatin with calcium ions. Depending on the concentrations of RFP, the loading efficiency of RFP in the composites varied in the range from approximately 2% to 5%. Moreover, the surface of these binary composites could be further coated by a biodegradable polymer, yielding biodegradable polymer-coated, RFP-containing gelatin hydrogel/TPB ternary composites. It was shown thatin vitrorelease of RFP from the ternary composites could be effectively sustained for a long period of time. Besides, these composites revealed good biocompatibility towards the survival of MC-3T3 cellsin vitroand could be used for tissue regenerationin vivoin a rabbit model. The results indicate that TPB ternary composites have great potential for the treatment of osteoarticular tuberculosis.
Collapse
Affiliation(s)
- Mintao Xue
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| | - Hongtao Hu
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| | - Yuanquan Jiang
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| | - Jichun Liu
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| | - Hailong He
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| | - Xiaojian Ye
- Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China
| |
Collapse
|
11
|
Zhu M, Wang H, Liu J, He H, Hua X, He Q, Zhang L, Ye X, Shi J. A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomaterials 2011; 32:1986-95. [PMID: 21163519 DOI: 10.1016/j.biomaterials.2010.11.025] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2010] [Accepted: 11/14/2010] [Indexed: 10/18/2022]
|
12
|
Trivedi R, Kompella UB. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond) 2010; 5:485-505. [PMID: 20394539 DOI: 10.2217/nnm.10.10] [Citation(s) in RCA: 236] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Micellar delivery systems smaller than 100 nm can be readily prepared. While micelles allow a great depth of tissue penetration for targeted drug delivery, they usually disintegrate rapidly in the body. Thus, sustained drug delivery from micellar nanocarriers is a challenge. This article summarizes various key strategies and underlying principles for sustained drug delivery using micellar nanocarriers. Comparisons are made with other competing delivery systems such as polymeric microparticles and nanoparticles. Amphiphilic molecules self-assemble in appropriate liquid media to form nanoscale micelles. Strategies for sustained release nanomicellar carriers include use of prodrugs, drug polymer conjugates, novel polymers with low critical micellar concentration or of a reverse thermoresponsive nature, reverse micelles, multi-layer micelles with layer by layer assembly, polymeric films capable of forming micelles in vivo and micelle coats on a solid support. These new micellar systems are promising for sustained drug delivery.
Collapse
Affiliation(s)
- Ruchit Trivedi
- Department of Pharmaceutical Sciences, University of Colorado Denver, 12700 E 19th Avenue, C238-P15, Aurora, CO 80045, USA
| | | |
Collapse
|
13
|
Abdulla JMA, Tan YTF, Darwis Y. Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization. AAPS PharmSciTech 2010; 11:663-71. [PMID: 20405256 DOI: 10.1208/s12249-010-9428-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2010] [Accepted: 04/05/2010] [Indexed: 11/30/2022] Open
Abstract
Rifampicin-loaded nanoparticles were prepared using two different molecular weights of poly-(ethylene oxide)-block-distearoyl phosphatidyl-ethanolamine (mPEG2000-DSPE and mPEG5000-DSPE) polymers. Particle sizes of all formulations studied were in the range of 162-395 nm. The entrapment efficiency (EE) was not affected by the copolymer's molecular weight, and the highest EE (100%) was obtained with drug to copolymer ratio of 1:5. The differential scanning calorimetry (DSC) thermograms showed Tg of rifampicin-loaded PEG-DSPE nanoparticles that shifted to a lower value, indicating entrapment of rifampicin in polymer matrix. The Fourier transformed infrared spectra revealed no chemical interactions between the drug and both copolymers. The in vitro drug release from the formulations occurred over 3 days and followed first-order release kinetic and Higuchi diffusion model. The nebulization of rehydrated lyophilized rifampicin mPEG-DSPE formulations had mass median aerodynamic diameter of 2.6 microm and fine particle fraction of 42%. The aerodynamic characteristic of the preparations was not influenced by the molecular weight of the copolymers. Therefore, it is suggested that both mPEG-DSPE are promising candidates as rifampicin carrier for pulmonary delivery.
Collapse
|
14
|
Onoshita T, Shimizu Y, Yamaya N, Miyazaki M, Yokoyama M, Fujiwara N, Nakajima T, Makino K, Terada H, Haga M. The behavior of PLGA microspheres containing rifampicin in alveolar macrophages. Colloids Surf B Biointerfaces 2010; 76:151-7. [DOI: 10.1016/j.colsurfb.2009.10.036] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2009] [Revised: 10/16/2009] [Accepted: 10/16/2009] [Indexed: 10/20/2022]
|
15
|
Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int J Pharm 2010; 387:187-98. [DOI: 10.1016/j.ijpharm.2009.11.033] [Citation(s) in RCA: 222] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2009] [Revised: 11/25/2009] [Accepted: 11/27/2009] [Indexed: 11/25/2022]
|
16
|
Devi N, Maji TK. Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–κ-carrageenan polyelectrolyte complex. Drug Dev Ind Pharm 2010; 36:56-63. [DOI: 10.3109/03639040903061355] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
17
|
Wang T, Jiang M, Wu Y. Nanoparticles composed of PLGA and hyperbranched poly (amine-ester) as a drug carrier. JOURNAL OF POLYMER RESEARCH 2009. [DOI: 10.1007/s10965-009-9320-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Bennewitz MF, Saltzman WM. Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics 2009; 6:323-36. [PMID: 19332327 PMCID: PMC2673491 DOI: 10.1016/j.nurt.2009.01.018] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2008] [Revised: 01/23/2009] [Accepted: 01/23/2009] [Indexed: 01/16/2023] Open
Abstract
Epilepsy results from aberrant electrical activity that can affect either a focal area or the entire brain. In treating epilepsy with drugs, the aim is to decrease seizure frequency and severity while minimizing toxicity to the brain and other tissues. Antiepileptic drugs (AEDs) are usually administered by oral and intravenous routes, but these drug treatments are not always effective. Drug access to the brain is severely limited by a number of biological factors, particularly the blood-brain barrier, which impedes the ability of AEDs to enter and remain in the brain. To improve the efficacy of AEDs, new drug delivery strategies are being developed; these methods fall into the three main categories: drug modification, blood-brain barrier modification, and direct drug delivery. Recently, all three methods have been improved through the use of drug-loaded nanoparticles.
Collapse
Affiliation(s)
- Margaret F. Bennewitz
- grid.47100.320000000419368710Department of Biomedical Engineering, Yale University, 414 Malone Engineering Center, 55 Prospect Street, 06520-8260 New Haven, CT
| | - W. Mark Saltzman
- grid.47100.320000000419368710Department of Biomedical Engineering, Yale University, 414 Malone Engineering Center, 55 Prospect Street, 06520-8260 New Haven, CT
| |
Collapse
|
19
|
Xie Y, Zeng P, Wiedmann TS. Disease guided optimization of the respiratory delivery of microparticulate formulations. Expert Opin Drug Deliv 2008; 5:269-89. [PMID: 18318650 DOI: 10.1517/17425247.5.3.269] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Inhalation of microparticulate dosage forms can be effectively used in the treatment of respiratory and systemic diseases. OBJECTIVE Disease states investigated for treatment by inhalation of microparticles were reviewed along with the drugs' pharmacological, pharmacokinetic and physical chemical properties to identify the advantages of microparticulate inhalation formulations and to identify areas for further improvement. METHODS Microbial infections of the lung, asthma, diabetes, lung transplantation and lung cancer were examined, with a focus on those systems intended to provide a sustained release. CONCLUSION In developing microparticulate formulations for inhalation in the lung, there is a need to understand the pharmacology of the drug as the key to revealing the optimal concentration time profile, the disease state, and the pharmacokinetic properties of the pure drug as determined by IV administration and inhalation. Finally, in vitro release studies will allow better identification of the best dosing strategy to be used in efficacy and safety studies.
Collapse
Affiliation(s)
- Yuanyuan Xie
- University of Minnesota, Department of Pharmaceutics, 308 Harvard St SE, Minneapolis, MN 55455, USA
| | | | | |
Collapse
|
20
|
Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin. Antimicrob Agents Chemother 2008; 52:2335-9. [PMID: 18411320 DOI: 10.1128/aac.01360-07] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A biodegradable system of poly-D,L-dilactide releasing ciprofloxacin was assessed in a Pseudomonas aeruginosa osteomyelitis model after inoculation of the test pathogen into the left tibia of 76 New Zealand White rabbits; 31 were controls (group A), and 45 were implanted with the polymer at the infection site (group B). The rabbits were killed on a weekly basis, and cancellous bone was harvested for histopathology and for estimation of bacterial growth and the concentrations of ciprofloxacin. Tibial X ray was performed immediately before the animals were killed. The total number of fistulas with purulent discharge that developed after inoculation of the pathogen was counted, and fistulas with purulent discharge were found in 16 animals in group A (51.6%) and 3 animals in group B (6.7%) (P < 0.0001). The animals in group A had a profound loss of body weight compared to the animals in group B. The main radiological finding was the presence of sequestra in 25 animals (80.6%) in group A and 6 animals in group B (13.3%) (P < 0.0001). The bacterial load in group B was significantly reduced compared to that in group A, possibly due to the prolonged local antibiotic release at concentrations exceeding even 80 times the MIC for the test pathogen. The histology of animals killed after week 49 revealed a mild inflammatory reaction accompanied by diffuse fibrosis and new bone formation in group A animals and the presence of small polymer particles in group B animals. It is concluded that the system described achieved eradication of the pathogen, accompanied by clinical and radiologically confirmed benefits, so this treatment may be a candidate for the management of difficult orthopedic infections.
Collapse
|
21
|
Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2007; 3:161-7. [PMID: 17468055 DOI: 10.1016/j.nano.2007.03.003] [Citation(s) in RCA: 97] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2007] [Revised: 02/21/2007] [Accepted: 03/02/2007] [Indexed: 10/23/2022]
Abstract
Biodegradable polymers such as poly lactide-co-glycolides (PLGA) have been considered for the preparation of nanoparticles (NPs). In this study, rifampicin (RIF)-loaded PLGA NPs were fabricated by an emulsification/solvent diffusion method. The effect of several variables on the NPs' characteristics were evaluated, including the amount of RIF, amount of the poly vinyl alcohol as surfactant, and internal-phase volume and composition. The RIF encapsulation efficacy and the particle size distribution were optimized by varying these parameters. NPs were spherical with a relatively monodispersed size distribution. The effect of nanoencapsulation of RIF on the antibacterial activity of RIF against gram-positive and gram-negative bacteria was evaluated. It was shown that RIF NPs could considerably improve the RIF antibacterial efficacy.
Collapse
Affiliation(s)
- Farnaz Esmaeili
- Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
| | | | | | | | | | | |
Collapse
|
22
|
Gu J, Xia F, Wu Y, Qu X, Yang Z, Jiang L. Programmable delivery of hydrophilic drug using dually responsive hydrogel cages. J Control Release 2007; 117:396-402. [PMID: 17239981 DOI: 10.1016/j.jconrel.2006.11.029] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2006] [Revised: 11/09/2006] [Accepted: 11/28/2006] [Indexed: 11/25/2022]
Abstract
Micro-capsules normally encapsulate therapeutic agents only inside their cavities. In this paper, we report on the synthesis of dually responsive poly(N-isopropylacrylamide) (PNiPAM)-co-acrylic acid (AA) hydrogel cages sub-micrometer in size and the use of these cages as drug carriers. The cavity structure of the cages can enhance volume phase transition compared to solid gel particles, thus favoring drug loading and release. TEM images and FT-IR spectra confirmed that the model drug isoniazid (INH) is located in two regions: within the shell and inside the cavity of the cages. The drugs residing in the shell can form hydrogen bonds with the cage matrix, while the drugs in the cavity are interaction free with the carrier. This difference from the residency of drugs exploited to a structure induced drug release which was programmable controlled by external pH and temperature. In vitro drug release studies showed that in a neutral medium (pH=7.4), major drugs were preserved within the shell, while in an acidic medium (pH=1.2), nearly all of the drugs were released due to the dissociation of hydrogen bonds.
Collapse
Affiliation(s)
- Jingxia Gu
- State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China
| | | | | | | | | | | |
Collapse
|
23
|
Troshkina OA, Salina EG, Sorokoumova GM, Kaprelyants AS, Selishcheva AA. The effect of liposomes on the growth and sensitivity of Mycobacterium smegmatis to isoniazide. APPL BIOCHEM MICRO+ 2007. [DOI: 10.1134/s0003683807010073] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
24
|
Kim MD, Iskakov RM, Batyrbekov EO, Zhubanov BA, Perichaud A. Segmented polyurethane-based microparticles: Synthesis, properties, and isoniazid encapsulation and kinetics of release. POLYMER SCIENCE SERIES A 2006. [DOI: 10.1134/s0965545x06120054] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
25
|
Ng KY, Zhou H, Zhang YL, Hybertson B, Randolph T, Christians U. Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography-tandem mass spectrometry with on-line extraction. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 847:188-98. [PMID: 17070115 DOI: 10.1016/j.jchromb.2006.10.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2005] [Revised: 10/04/2006] [Accepted: 10/06/2006] [Indexed: 10/24/2022]
Abstract
To evaluate if pulmonary delivery of microparticles loaded with a prodrug of isoniazid (INH), isoniazid methanesulfonate (INHMS), can target alveolar macrophages (AM) and reduce metabolism of INH, an HPLC-MS/MS assay with automated online extraction for quantification of INH and its metabolite acetylisoniazid (AcINH) in plasma and AMs was developed and validated. Reproducibility in rat plasma and homogenate of a rat AM cell line, NR8383, for INH and AcINH showed excellent precision and accuracy with calibration curves exhibiting linearity within a range of 1-250ng/ml of INH and 0.05-50ng/ml of AcINH (r(2)>0.99). The validated methods were successfully applied to pharmacokinetic study of INHMS-loaded microparticles in rats, demonstrating efficient targeting of AMs and reduction of INH metabolism.
Collapse
Affiliation(s)
- Ka-yun Ng
- Department of Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
| | | | | | | | | | | |
Collapse
|
26
|
Bajpai P, Vedi S, Owais M, Sharma SK, Saxena PN, Misra-Bhattacharya S. Use of liposomized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model. J Drug Target 2005; 13:375-81. [PMID: 16278157 DOI: 10.1080/10611860500285439] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Wolbachia bacteria, being filarial parasite symbiont have been implicated in a variety of roles, including development, fecundity and the pathogenesis of the filarial infections. Among various strategies used in the treatment of experimental filariasis, the elimination of symbiont Wolbachia seem to offer an efficient means of curing the disease. The antiwolbachial property of tetracycline has been well worked out; however, treatment needs to be continued for a prolonged period of time to achieve complete elimination of Wolbachia from the filarial parasites and their subsequent killing. This results in acute toxicity, thus limiting its practical utility for clinical implementation. In order to increase efficacy of the antibiotic with minimal toxic manifestations, we developed liposomized formulation of the tetracycline. The liposomized tetracycline was found to be significantly more effective when compared to the free form of the drug. In contrast to the 90/120 days oral administration of the drug, the treatment schedule using the liposomized form of the drug was reduced to 12 alternate days with better efficacy of the treatment.
Collapse
Affiliation(s)
- Preeti Bajpai
- Central Drug Research Institute, Divisions of Parasitology, Lucknow, India
| | | | | | | | | | | |
Collapse
|
27
|
Zhou H, Zhang Y, Biggs DL, Manning MC, Randolph TW, Christians U, Hybertson BM, Ng KY. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. J Control Release 2005; 107:288-99. [PMID: 16009444 DOI: 10.1016/j.jconrel.2005.06.009] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2005] [Revised: 06/16/2005] [Accepted: 06/17/2005] [Indexed: 10/25/2022]
Abstract
Microparticles prepared by the precipitation with a compressed antisolvent (PCA) process were evaluated for their potential in targeting an ionizable prodrug of isoniazid (INH), isoniazid methanesulfonate (INHMS), for sustained delivery of INH to alveolar macrophages (AMs). The charged prodrug was ion-paired with two different hydrophobic cations (tetrapentylammonium (TPA)- and tetraheptylammonium (THA)-bromide), and loaded separately into the poly(l-lactide) (PLA) microparticles. The drug/polymer particles were spherical in shape and between 1 and 3 mum in diameter. The choice of hydrophobic cations did not affect drug incorporation efficiencies or the release kinetics of INH from the microparticles. Using a sensitive liquid chromatographic tandem mass spectrometric (LC-MS/MS) assay developed for INH, high level of INH was detected in NR8383, a rat AM cell line, following exposure of these cells to drug-loaded microparticles. To confirm the microparticles can target AMs in vivo, we compared the INH levels in lavaged bronchoalveolar macrophages by LC-MS/MS after the Sprague-Dawley rats were administered either INHMS in PLA microparticles by intra-tracheal instillation or INH solution by gavage or intra-tracheal instillation. As expected, only microparticles provided sustained and targeted delivery of INH to AMs. Most importantly, this method of delivery led to substantial reduction in the blood levels of acetylisoniazid (AcINH), a major and potential toxic metabolite of INH.
Collapse
Affiliation(s)
- Huiyu Zhou
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Campus Box C238, Denver, CO 80262, USA
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Mariappan TT, Jindal KC, Singh S. Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone. J Pharm Biomed Anal 2004; 36:905-8. [PMID: 15533688 DOI: 10.1016/j.jpba.2004.08.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2004] [Revised: 08/12/2004] [Accepted: 08/12/2004] [Indexed: 11/17/2022]
Abstract
When present together in fixed-dose combinations (FDC) of anti-tuberculosis drugs, rifampicin (R) and isoniazid (H) interact with each other to form isonicotinyl hydrazone (HYD). In a preliminary study, this product was found to possess similar colorimetric spectrum to that of rifampicin. Therefore, an investigation was undertaken to determine interference of HYD during analysis of rifampicin in FDC products by colorimetry. For the purpose, standard plots were constructed for rifampicin and HYD at 475 nm, the wavelength maximum for both the compounds. The plots were linear in the range of 10-100 microg/ml. Molar absorptivity values for rifampicin and HYD were 15279 and 5034, respectively. It indicated that HYD possessed one-third absorptivity to that of rifampicin. The analysis of combinations of rifampicin and HYD revealed that rifampicin could be overestimated to a maximum extent of 33%, while interference varied at other relative ratios of the two compounds. This was also confirmed by colorimetric and HPLC analysis of a degraded marketed product and samples from a dissolution study. Thus this investigation suggests that any method devoid of interference of HYD should be preferred for analysis of rifampicin, whenever it is present along with isoniazid.
Collapse
Affiliation(s)
- T T Mariappan
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab, India
| | | | | |
Collapse
|
29
|
Tyagi AK, Dhar N. Recent advances in tuberculosis research in India. ADVANCES IN BIOCHEMICAL ENGINEERING/BIOTECHNOLOGY 2003; 84:211-73. [PMID: 12934938 DOI: 10.1007/3-540-36488-9_7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Tuberculosis (TB) continues to be the leading killer of mankind among all infectious diseases, especially in the developing countries. Since the discovery of tubercle bacillus more than 100 years ago, TB has been the subject of research in an attempt to develop tools and strategies to combat this disease. Research in Indian laboratories has contributed significantly towards developing the DOTS strategy employed worldwide in tuberculosis control programmes and elucidating the biological properties of its etiologic agent, M. tuberculosis. In recent times, the development of tools for manipulation of mycobacteria has given a boost to researchers working in this field. New strategies are being employed towards understanding the mechanisms of protection and pathogenesis of this disease. Molecular methods are being applied to develop new tools and reagents for prevention, diagnosis and treatment of tuberculosis. With the sequencing of the genome of M. tuberculosis, molecules are being identified for the development of new drugs and vaccines. In this chapter, the advances made in these areas by Indian researchers mainly during the last five years are reviewed.
Collapse
Affiliation(s)
- Anil K Tyagi
- Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, New Delhi-110021, India.
| | | |
Collapse
|